Paper23812596
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.
Prieto-Alhambra D and 5 others. Osteoporos Int, 2014. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial. Papers, record 23812596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23812596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cognition Disorders | Major topic |
| Hip Fractures | Major topic |
| Osteoporotic Fractures | Major topic |
| Aged | |
| Aged, 80 and over | |
| Bone Density Conservation Agents | |
| Diphosphonates | |
| Double-Blind Method | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Imidazoles | |
| Incidence | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Osteoporosis | |
| Psychiatric Status Rating Scales | |
| Secondary Prevention | |
| Treatment Outcome | |
| Zoledronic Acid |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MC_U147585819 | Medical Research Council | United Kingdom | PubMed | |
| MC_UP_A620_1014 | Medical Research Council | United Kingdom | PubMed | |
| MC_UU_12011/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00046254 | Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture | Derived from the trial | Yes |
Source ClinicalTrials.gov
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22736068 | Competing mortality and fracture risk assessment. | Osteoporos Int | 2013 | https://conductscience.org/library/papers/22736068 | PubMed |
| 2 | 20103398 | Prediction of postoperative ambulatory status 1 year after hip fracture surgery. | Arch Phys Med Rehabil | 2010 | https://conductscience.org/library/papers/20103398 | PubMed |
| 3 | 19264957 | Recurrent and injurious falls in the year following hip fracture: a prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture study. | J Gerontol A Biol Sci Med Sci | 2009 | https://conductscience.org/library/papers/19264957 | PubMed |
| 4 | 1544951 | Factors which influence mortality after subcapital hip fracture. | J Bone Joint Surg Br | 1992 | https://conductscience.org/library/papers/1544951 | PubMed |
| 5 | 12543843 | Interaction revisited: the difference between two estimates. | BMJ | 2003 | https://conductscience.org/library/papers/12543843 | PubMed |
| 6 | 21607807 | Coordinator-based systems for secondary prevention in fragility fracture patients. | Osteoporos Int | 2011 | https://conductscience.org/library/papers/21607807 | PubMed |
| 7 | 21278153 | Nottingham Hip Fracture Score as a predictor of one year mortality in patients undergoing surgical repair of fractured neck of femur. | Br J Anaesth | 2011 | https://conductscience.org/library/papers/21278153 | PubMed |
| 8 | 20354011 | Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. | BMJ | 2010 | https://conductscience.org/library/papers/20354011 | PubMed |
| 9 | 7554702 | Studies of the oral bioavailability of alendronate. | Clin Pharmacol Ther | 1995 | https://conductscience.org/library/papers/7554702 | PubMed |
| 10 | 1159263 | A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. | J Am Geriatr Soc | 1975 | https://conductscience.org/library/papers/1159263 | PubMed |
| 11 | 20085954 | The patient who falls: "It's always a trade-off". | JAMA | 2010 | https://conductscience.org/library/papers/20085954 | PubMed |
| 12 | 10206606 | Cognitive status at admission: does it affect the rehabilitation outcome of elderly patients with hip fracture? | Arch Phys Med Rehabil | 1999 | https://conductscience.org/library/papers/10206606 | PubMed |
| 13 | 20345862 | Competing risk of death: an important consideration in studies of older adults. | J Am Geriatr Soc | 2010 | https://conductscience.org/library/papers/20345862 | PubMed |
| 14 | 17476007 | Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17476007 | PubMed |
| 15 | 8366261 | Identifying elderly patients for early discharge after hospitalization for hip fracture. | J Gerontol | 1993 | https://conductscience.org/library/papers/8366261 | PubMed |
| 16 | 22422832 | Credibility of claims of subgroup effects in randomised controlled trials: systematic review. | BMJ | 2012 | https://conductscience.org/library/papers/22422832 | PubMed |
| 17 | 7298685 | Cardiovascular and neurological function in elderly patients sustaining a fracture of the neck of the femur. | J Bone Joint Surg Br | 1981 | https://conductscience.org/library/papers/7298685 | PubMed |
| 18 | 17702879 | Factors associated with pharmacologic treatment of osteoporosis in an older home care population. | J Gerontol A Biol Sci Med Sci | 2007 | https://conductscience.org/library/papers/17702879 | PubMed |
| 19 | 16087821 | The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. | Arch Intern Med | 2005 | https://conductscience.org/library/papers/16087821 | PubMed |
| 20 | 20889095 | Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. | J Am Med Dir Assoc | 2010 | https://conductscience.org/library/papers/20889095 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40369405 | Impact of multidimensional assessment on anti-fracture treatment decisions in patients with fragility hip fractures within a Fracture Liaison Service. | BMC Geriatr | 2025 | https://conductscience.org/library/papers/40369405 | PubMed |
| 39566233 | Enabling osteoporosis treatment in post-acute care: An algorithm for providers. | Geriatr Nurs | 2025 | https://conductscience.org/library/papers/39566233 | PubMed |
| 37614297 | Advantages and Disadvantages of Random Forest Models for Prediction of Hip Fracture Risk Versus Mortality Risk in the Oldest Old. | JBMR Plus | 2023 | https://conductscience.org/library/papers/37614297 | PubMed |
| 37552293 | Clinical and biological parameters associated with fracture recurrence according to fracture liaison service dataset. | Osteoporos Int | 2023 | https://conductscience.org/library/papers/37552293 | PubMed |
| 37428295 | Current approaches to secondary prevention after hip fracture in England and Wales - an analysis of trends between 2016 and 2020 using the National Hip Fracture Database (NHFD). | Arch Osteoporos | 2023 | https://conductscience.org/library/papers/37428295 | PubMed |
| 37231406 | Post-surgery interventions for hip fracture: a systematic review of randomized controlled trials. | BMC Musculoskelet Disord | 2023 | https://conductscience.org/library/papers/37231406 | PubMed |
| 34341833 | Zoledronic acid and bone health in older adults with cognitive impairment. | Osteoporos Int | 2022 | https://conductscience.org/library/papers/34341833 | PubMed |
| 33923261 | Adherence to Anti-Osteoporotic Treatment and Clinical Implications after Hip Fracture: A Systematic Review. | J Pers Med | 2021 | https://conductscience.org/library/papers/33923261 | PubMed |
| 30575958 | Effect of Bisphosphonates on Fracture Outcomes Among Frail Older Adults. | J Am Geriatr Soc | 2019 | https://conductscience.org/library/papers/30575958 | PubMed |
| 29463292 | Effectiveness of interventions aimed at improving physical and psychological outcomes of fall-related injuries in people with dementia: a narrative systematic review. | Syst Rev | 2018 | https://conductscience.org/library/papers/29463292 | PubMed |
| 28958013 | Fracture Risk Assessment in Long-term Care (FRAiL): Development and Validation of a Prediction Model. | J Gerontol A Biol Sci Med Sci | 2018 | https://conductscience.org/library/papers/28958013 | PubMed |
| 25660252 | Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. | Am J Med | 2015 | https://conductscience.org/library/papers/25660252 | PubMed |
| 24980182 | Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital's fracture liaison service between January 2010 and December 2011. | Osteoporos Int | 2014 | https://conductscience.org/library/papers/24980182 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| ZOLEDRONIC ACID | CHEMBL4303669 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL4303669 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23812596
GET https://conductscience.org/api/papers/v1/23812596/references?page=2